Skin News and Research

RSS

Mere presence in a room can add 37 million bacteria

A person's mere presence in a room can add 37 million bacteria to the air every hour - material largely left behind by previous occupants and stirred up from the floor - according to new research by Yale University engineers.

29 Mar 2012

Tips to help ensure best plastic surgery results

Believe it or not, you play just as big a role in the overall success of your cosmetic surgery as your surgeon. Board certified plastic surgeon Dr. Gregory A. Buford recently published a comprehensive list of tips to help ensure the best results, no matter what procedure you're preparing for.

29 Mar 2012

Perspectives on health law challenge: Does court recognize its own limits?; A dubious link to Civil Rights Act; The burden on young people

In ruling on the constitutionality of requiring most Americans to obtain health insurance, the Supreme Court faces a central test: whether it will recognize limits on its own authority to overturn well-founded acts of Congress.

29 Mar 2012

IMRT associated with reduced toxicities when compared with standard whole breast irradiation

Breast cancer patients treated with intensity modulated radiation therapy (IMRT) instead of standard whole breast irradiation (WBI) have a lower incidence of acute or chronic toxicities, according to a study in Practical Radiation Oncology (PRO), the official clinical practice journal of the American Society for Radiation Oncology (ASTRO).

29 Mar 2012

NEJM publishes results from Amgen's brodalumab Phase 2 trial on plaque psoriasis

Amgen announced today that results from a Phase 2 trial evaluating the safety and efficacy of brodalumab in 198 patients with moderate to severe plaque psoriasis were published in the New England Journal of Medicine.

29 Mar 2012

Helix BioMedix 2011 revenue increases 122% to record $1.9 million

Helix BioMedix, Inc., a developer of bioactive peptides, today announced financial results for the year ended December 31, 2011.

29 Mar 2012

Specific precautions must be taken for individuals on longer-term oral glucocorticoid therapy

Millions of people around the world are prescribed glucocorticoids for a wide variety of inflammatory conditions, including, rheumatoid arthritis, asthma and inflammatory bowel diseases. Although they are effective and widely used, one of the potentially serious side effects of these medications is glucocorticoid-induced osteoporosis.

28 Mar 2012

Therapy Finder - Colorectal Cancer app now available for patients

No one wants to hear the words, "you have colon cancer." For patients diagnosed with an advanced form of the disease, these words can be particularly devastating. The five-year survival rate can be a little as 6 percent. The top-of-mind question becomes, "Which treatment or clinical trial will work for me?"

28 Mar 2012

Surfaxin receives FDA approval for prevention of RDS in premature infants

The U.S. Food and Drug Administration today approved Surfaxin (lucinactant) for the prevention of respiratory distress syndrome (RDS), a breathing disorder that affects premature infants.

27 Mar 2012

Hapten licenses HPT-721 to prevent poison ivy dermatitis

Hapten Sciences Inc. of Memphis, Tenn., has licensed a compound developed by ElSohly Laboratories Inc. and University of Mississippi pharmaceutical researchers to prevent reactions to poison ivy, oak and sumac.

27 Mar 2012

First study to explore differential gender effects of secondhand smoke exposure

The negative health effects of early-life exposure to secondhand smoke appear to impact girls more than boys-particularly those with early-life allergic sensitization, according to new research from the University of Cincinnati (UC) College of Medicine.

27 Mar 2012

Minimally invasive treatments re-establish blood flow in people with chronic DVT

Interventional radiology treatments re-establish blood flow in people with chronic deep vein thrombosis (DVT), reducing disabling symptoms and improving the quality of life for those afflicted with post-thrombotic syndrome—an under-recognized but frequent long-term complication of DVT.

27 Mar 2012

Researchers use skin cells from MND patient to create motor neurones

A breakthrough using cutting-edge stem cell research could speed up the discovery of new treatments for motor neurone disease (MND).

27 Mar 2012

Tips to prevent tick-borne diseases

Spring has only just arrived, but tick season is well under way. Physicians are seeing new cases of tick-borne illness several weeks earlier than usual, likely because a mild winter in much of the country made life easier for ticks and their offspring. That means it's time for gardeners, hikers, pet owners and others who spend time outdoors to take steps to protect themselves -- and to watch for symptoms of tick-borne illness if they do come in contact with the tiny bloodsuckers.

27 Mar 2012

DBS allows surgeons to control tremors with brain 'pacemaker'

For nearly 30 years, Tom Rogers' left hand would shake when he tried to use it, making even simple tasks such as drinking a glass of water, writing a check, or making a sandwich challenging. The tremor eventually became so disruptive that he lost use of his dominant hand. Rogers sought care and learned that his tremor was a symptom of Parkinson's disease, yet felt he was suffering from something different.

27 Mar 2012

USANA Health Sciences expands into French and Belgium markets

USANA Health Sciences, Inc., a global nutritional supplements company, today announced the official opening of its France and Belgium markets. Bringing the company's international expansion to 18 countries worldwide, USANA's newest office will reside on the Champs-Elysees in Paris and will initially offer seven nutritional supplements and eight skin-care products.

26 Mar 2012

New compendium on head injury biomechanics

SAE International offers a 3-volume set Head Injury Biomechanics, edited by Jeffrey A. Pike, which is designed to aid those studying head injury from a broad range of causes, including transportation, falls, sports, personal violence, and blast-related.

26 Mar 2012

Percutaneous cryoablation freezes and destroys breast cancer tumors

Individuals fighting metastatic breast cancer, where the disease has progressed to other areas of the body, may finally have another weapon in their arsenal: percutaneous cryoablation.

26 Mar 2012

Breast implant materials may deter cancer cells from dwelling and thriving

One in eight women in the United States will develop breast cancer. Of those, many will undergo surgery to remove the tumor and will require some kind of breast reconstruction afterward, often involving implants. Cancer is an elusive target, though, and malignant cells return for as many as one-fifth of women originally diagnosed, according to the American Cancer Society.

26 Mar 2012

Medgenics to commence EPODURE Biopumps Phase IIa study in ESRD-related anemia

Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced receipt of clearance from the Israeli Ministry of Health to initiate a Phase IIa clinical study evaluating the safety and efficacy of sustained erythropoietin therapy produced and delivered by the Company's EPODURE Biopumps.

26 Mar 2012